{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:29:54Z","timestamp":1772177394837,"version":"3.50.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1003308","type":"journal-article","created":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T13:22:40Z","timestamp":1599571360000},"page":"e1003308","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":70,"title":["Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8651-6072","authenticated-orcid":true,"given":"Lars Christian","family":"Lund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6373-1386","authenticated-orcid":true,"given":"Kasper Bruun","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1241-4385","authenticated-orcid":true,"given":"Mette","family":"Reilev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9135-3474","authenticated-orcid":true,"given":"Reimar Wernich","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0727-953X","authenticated-orcid":true,"given":"Christian Fynbo","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5821-2351","authenticated-orcid":true,"given":"Henrik","family":"St\u00f8vring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3764-8532","authenticated-orcid":true,"given":"Nanna Borup","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolai Constantin","family":"Brun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8097-8708","authenticated-orcid":true,"given":"Jesper","family":"Hallas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9314-5679","authenticated-orcid":true,"given":"Anton","family":"Potteg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,9,8]]},"reference":[{"key":"pmed.1003308.ref001","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"L Fang","year":"2020","journal-title":"Lancet Respir Med."},{"key":"pmed.1003308.ref002","doi-asserted-by":"crossref","first-page":"m1086","DOI":"10.1136\/bmj.m1086","article-title":"Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists","volume":"368","author":"M Day","year":"2020","journal-title":"BMJ"},{"key":"pmed.1003308.ref003","unstructured":"European Medicines Agency. EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19. EMA\/136850\/2020. Amsterdam: European Medicines Agency; 2020 [cited 2020 Aug 3]. Available from: https:\/\/www.ema.europa.eu\/en\/news\/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19."},{"key":"pmed.1003308.ref004","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1164\/rccm.201802-0229LE","article-title":"Nonsteroidal antiinflammatory drug use and clinical outcomes of community-acquired pneumonia","volume":"198","author":"D Basille","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"pmed.1003308.ref005","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3390\/jcm8060786","article-title":"Risks related to the use of non-steroidal anti-inflammatory drugs in community-acquired pneumonia in adult and pediatric patients.","volume":"8","author":"G Voiriot","year":"2019","journal-title":"J Clin Med"},{"key":"pmed.1003308.ref006","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12098-018-2769-y","article-title":"Predicting complicated parapneumonic effusion in community acquired pneumonia: hospital based case-control study","volume":"86","author":"P Meganathan","year":"2019","journal-title":"Indian J Pediatr"},{"key":"pmed.1003308.ref007","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jcrc.2014.05.021","article-title":"Risks of nonsteroidal antiinflammatory drugs in undiagnosed intensive care unit pneumococcal pneumonia: younger and more severely affected patients.","volume":"29","author":"J Messika","year":"2014","journal-title":"J Crit Care"},{"key":"pmed.1003308.ref008","doi-asserted-by":"crossref","first-page":"248","DOI":"10.7883\/yoken.JJID.2014.577","article-title":"Nonsteroidal anti-inflammatory drug and aspirin use, and mortality among critically ill pandemic H1N1 influenza patients: an exploratory analysis","volume":"69","author":"H Epperly","year":"2016","journal-title":"Jpn J Infect Dis"},{"key":"pmed.1003308.ref009","doi-asserted-by":"crossref","first-page":"e2013880","DOI":"10.1001\/jamanetworkopen.2020.13880","article-title":"Association of nonsteroidal anti-inflammatory drug use and adverse outcomes among patients hospitalized with influenza","volume":"3","author":"LC Lund","year":"2020","journal-title":"JAMA Netw Open."},{"key":"pmed.1003308.ref010","unstructured":"European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. Use of non-steroidal anti-inflammatory drugs and clinical outcome of COVID-19: a Danish nationwide cohort study. EUPAS34734. Amsterdam: European Network of Centres for Pharmacoepidemiology and Pharmacovigilance; 2020 [cited 2020 Aug 3]. Available from: http:\/\/www.encepp.eu\/encepp\/viewResource.htm?id=34735."},{"key":"pmed.1003308.ref011","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1403494811399956","article-title":"Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving.","volume":"39","author":"LC Thygesen","year":"2011","journal-title":"Scand J Public Health."},{"key":"pmed.1003308.ref012","article-title":"Existing data sources in clinical epidemiology: the Danish COVID-19 cohort.","author":"A Potteg\u00e5rd","journal-title":"Clin Epidemiol"},{"key":"pmed.1003308.ref013","doi-asserted-by":"crossref","first-page":"20667","DOI":"10.2807\/1560-7917.ES2014.19.1.20667","article-title":"MiBa Board of Representatives. The Danish Microbiology Database (MiBa) 2010 to 2013","volume":"19","author":"M Voldstedlund","year":"2014","journal-title":"Euro Surveill"},{"key":"pmed.1003308.ref014","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/CLEP.S179083","article-title":"The Danish health care system and epidemiological research: from health care contacts to database records.","volume":"11","author":"M Schmidt","year":"2019","journal-title":"Clin Epidemiol"},{"key":"pmed.1003308.ref015","first-page":"798","article-title":"Data resource profile: the Danish National Prescription Registry.","volume":"46","author":"A Potteg\u00e5rd","year":"2017","journal-title":"Int J Epidemiol"},{"key":"pmed.1003308.ref016","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential.","volume":"7","author":"M Schmidt","year":"2015","journal-title":"Clin Epidemiol."},{"key":"pmed.1003308.ref017","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1403494811399958","article-title":"The Danish Register of Causes of Death.","volume":"39","author":"K Helweg-Larsen","year":"2011","journal-title":"Scand J Public Health."},{"key":"pmed.1003308.ref018","first-page":"9","article-title":"Validity of the coding for intensive care admission, mechanical ventilation, and acute dialysis in the Danish National Patient Registry: a short report.","volume":"5","author":"L Blichert-Hansen","year":"2013","journal-title":"Clin Epidemiol."},{"key":"pmed.1003308.ref019","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/CLEP.S59156","article-title":"Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999\u20132012.","volume":"6","author":"M Schmidt","year":"2014","journal-title":"Clin Epidemiol."},{"key":"pmed.1003308.ref020","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/ije\/dyw116","article-title":"Data resource profile: Danish online drug use statistics (MEDSTAT).","volume":"45","author":"M Schmidt","year":"2016","journal-title":"Int J Epidemiol"},{"key":"pmed.1003308.ref021","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/phar.2217","article-title":"Nonaspirin nonsteroidal antiinflammatory drug use in the Nordic countries from a cardiovascular risk perspective, 2000\u20132016: a drug utilization study.","volume":"39","author":"KB Kristensen","year":"2019","journal-title":"Pharmacotherapy"},{"key":"pmed.1003308.ref022","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"PR Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"pmed.1003308.ref023","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/aje\/kwq198","article-title":"Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution\u2014a simulation study","volume":"172","author":"T Sturmer","year":"2010","journal-title":"Am J Epidemiol"},{"key":"pmed.1003308.ref024","volume-title":"PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing","author":"E Leuven","year":"2018"},{"key":"pmed.1003308.ref025","article-title":"Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic.","author":"A Potteg\u00e5rd","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"pmed.1003308.ref026","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/sim.6058","article-title":"Metrics for covariate balance in cohort studies of causal effects: metrics for covariate balance in cohort studies of causal effects.","volume":"33","author":"JM Franklin","year":"2014","journal-title":"Stat Med."},{"key":"pmed.1003308.ref027","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/pds.2256","article-title":"Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses.","volume":"21","author":"JA Rassen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"pmed.1003308.ref028","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2147\/CLEP.S214909","article-title":"Validity of ICD-10 diagnoses of overweight and obesity in Danish hospitals.","volume":"11","author":"SB Gribsholt","year":"2019","journal-title":"Clin Epidemiol."},{"key":"pmed.1003308.ref029","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/00001648-200111000-00017","article-title":"Paradoxical relations of drug treatment with mortality in older persons.","volume":"12","author":"RJ Glynn","year":"2001","journal-title":"Epidemiol"},{"key":"pmed.1003308.ref030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/ehjcvp\/pvv054","article-title":"Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology","volume":"2","author":"M Schmidt","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"pmed.1003308.ref031","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000375362","article-title":"Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats.","volume":"131","author":"W Qiao","year":"2015","journal-title":"Cardiology"},{"key":"pmed.1003308.ref032","article-title":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19).","author":"N Mehta","year":"2020","journal-title":"JAMA Cardiol."},{"key":"pmed.1003308.ref033","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19","volume":"382","author":"G Mancia","year":"2020","journal-title":"N Engl J Med"},{"key":"pmed.1003308.ref034","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of Covid-19","volume":"382","author":"HR Reynolds","year":"2020","journal-title":"N Engl J Med"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T13:23:16Z","timestamp":1599571396000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003308"}},"subtitle":[],"editor":[{"given":"Anne C.","family":"Cunningham","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,9,8]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003308","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.08.20115683","asserted-by":"object"}]},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,8]]}}}